The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Naxitamab and granulocyte macrophage colony stimulating factor (GM-CSF) in combination with irinotecan and temozolomide in patients with high-risk neuroblastoma with primary refractory disease or in first relapse: An international, single-arm, multicenter phase 2 trial.
 
Godfrey Chi-Fung Chan
Leadership - Pangenia; Xellera Therapeutics
Consulting or Advisory Role - Pangenia; Xellera Therapeutics
Speakers' Bureau - Pangenia; Xellera Therapeutics
Patents, Royalties, Other Intellectual Property - Pangenia; Xellera Therapeutics
 
Charlotte Hindsberger
Employment - Ymabs Therapeutics Inc
Stock and Other Ownership Interests - Novo Nordisk; Ymabs Therapeutics Inc
Honoraria - Ymabs Therapeutics Inc
Consulting or Advisory Role - MC2 Pharma; Novo Nordisk
 
Anni Morsing
Employment - Y-mAbs Therapeutics
Stock and Other Ownership Interests - Y-mAbs Therapeutics
 
Steen Lisby
Employment - Y-mAbs Therapeutics
Leadership - Y-mAbs Therapeutics
Stock and Other Ownership Interests - Y-mAbs Therapeutics